About TELA Bio
TELA Bio is a company based in Malvern (United States) founded in 2012 by Antony Koblish.. TELA Bio has raised $104.6 million across 10 funding rounds from investors including ProMedica and Checkmate Capital. The company has 209 employees as of December 31, 2024. TELA Bio offers products and services including OviTex and OviTex PRS. TELA Bio operates in a competitive market with competitors including Deep Blue Medical Advance, Via Surgical, Ariste Medical, ArTack Medical and Polytouch Medical, among others.
- Headquarter Malvern, United States
- Employees 209 as on 31 Dec, 2024
- Founders Antony Koblish
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Tela Bio, Inc.
-
Annual Revenue
$69.3 M18.56as on Dec 31, 2024
-
Net Profit
$-37.84 M18.91as on Dec 31, 2024
-
EBITDA
$-40.68 M5.97as on Dec 31, 2024
-
Total Equity Funding
$104.6 M (USD)
in 10 rounds
-
Latest Funding Round
$10.62 M (USD), Series B
Jul 10, 2019
-
Investors
ProMedica
& 1 more
-
Employee Count
209
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of TELA Bio
TELA Bio is a publicly listed company on the NASDAQ with ticker symbol TELA in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of TELA Bio
TELA Bio offers a comprehensive portfolio of products and services, including OviTex and OviTex PRS. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Matrix for hernia repair with low polymer to enhance natural healing.
Biologic for plastic surgery to facilitate functional remodeling.
Unlock access to complete
Unlock access to complete
Software Development Team
19 people
Sales and Marketing
17 people
Leadership Team
16 people
Operations Team
7 people
Finance and Accounting
5 people
Product Management Team
5 people
Senior Team
3 people
Associate Team
1 people
Unlock access to complete
Funding Insights of TELA Bio
TELA Bio has successfully raised a total of $104.6M across 10 strategic funding rounds. The most recent funding activity was a Series B round of $10.62 million completed in July 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Series B — $10.6M
-
First Round
First Round
(06 Dec 2012)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2019 | Amount | Series B - TELA Bio | Valuation |
investors |
|
| Dec, 2018 | Amount | Series B - TELA Bio | Valuation |
investors |
|
| Apr, 2018 | Amount | Series B - TELA Bio | Valuation | Checkmate Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in TELA Bio
TELA Bio has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include ProMedica and Checkmate Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Checkmate Capital is backed by family office for private equity.
|
Founded Year | Domain | Location | |
|
Healthcare services are delivered by ProMedica health system.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by TELA Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - TELA Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tela Bio Comparisons
Competitors of TELA Bio
TELA Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Deep Blue Medical Advance, Via Surgical, Ariste Medical, ArTack Medical and Polytouch Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Hernia mesh devices are developed to treat and prevent recurrences.
|
|
| domain | founded_year | HQ Location |
Transfascial suture fixation devices for hernia repair are provided.
|
|
| domain | founded_year | HQ Location |
Drug-eluting surgical implants are developed to prevent device failure.
|
|
| domain | founded_year | HQ Location |
Specializes in manufacturing hernia mesh fixation devices for medical applications.
|
|
| domain | founded_year | HQ Location |
Laproscopic soft tissue prosthetic placement solutions
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Tela Bio
Frequently Asked Questions about TELA Bio
When was TELA Bio founded?
TELA Bio was founded in 2012.
Where is TELA Bio located?
TELA Bio is headquartered in Malvern, United States. It is registered at Malvern, Pennsylvania, United States.
Who is the current CEO of TELA Bio?
Antony Koblish is the current CEO of TELA Bio. They have also founded this company.
Is TELA Bio a funded company?
TELA Bio is a funded company, having raised a total of $104.6M across 10 funding rounds to date. The company's 1st funding round was a Series B of $500K, raised on Dec 06, 2012.
How many employees does TELA Bio have?
As of Dec 31, 2024, the latest employee count at TELA Bio is 209.
What is the annual revenue of TELA Bio?
Annual revenue of TELA Bio is $69.3M as on Dec 31, 2024.
What does TELA Bio do?
TELA Bio was established in 2012 in Malvern, United States, within the medical devices sector. Surgical solutions for vertical hernia repair and abdominal wall reconstruction are developed and supplied. Soft-tissue reconstruction products are designed to support the bodys natural healing processes, with reduced reliance on permanent synthetic materials over time. Operations focus on innovative devices that address clinical needs in soft-tissue repair.
Who are the top competitors of TELA Bio?
TELA Bio's top competitors include Deep Blue Medical Advance, Via Surgical and Ariste Medical.
What products or services does TELA Bio offer?
TELA Bio offers OviTex and OviTex PRS.
Is TELA Bio publicly traded?
Yes, TELA Bio is publicly traded on NASDAQ under the ticker symbol TELA.
Who are TELA Bio's investors?
TELA Bio has 2 investors. Key investors include ProMedica, and Checkmate Capital.
What is TELA Bio's ticker symbol?
The ticker symbol of TELA Bio is TELA on NASDAQ.